Evidence map›Paper›PMID 41090832›Full record

ArticleNanomaterials (Basel, Switzerland)2025

One-Pot Synthesis for Doped Amorphous Carbon-Based Compounds: Influence of ZnO Dopant on the Charge Transfer Efficiency.

Bernardo Alberto Vargas-Vidal, Esperanza Baños-López, María Del Rosario Munguía-Fuentes, Yazmín Mariela Hernández-Rodríguez, Oscar Eduardo Cigarroa-Mayorga

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bernardo Alberto Vargas-VidalDepartment Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Ciudad de México 07340, Mexico.
Esperanza Baños-LópezDepartment Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Ciudad de México 07340, Mexico.
María Del Rosario Munguía-FuentesDepartment Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Ciudad de México 07340, Mexico.
Yazmín Mariela Hernández-RodríguezDepartment Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Ciudad de México 07340, Mexico.
Oscar Eduardo Cigarroa-MayorgaDepartment Advanced Technologies, UPIITA-Instituto Politécnico Nacional, Av. IPN 2580, Ciudad de México 07340, Mexico.ORCID 0000-0002-9171-3529

Funding

Instituto Politécnico Nacional SIP 20254060
6 · The paper itself

Abstract

Amorphous carbon (a-C) materials have attracted significant attention for environmental remediation due to their chemical stability and high surface area; however, their photocatalytic activity remains limited by rapid electron-hole recombination. In this study, ZnO-doped amorphous carbon (a-C@ZnO) composites were synthesized via a one-pot hydrothermal method to enhance charge separation and photocatalytic performance. The synthesis involved the carbonization of glucose and the incorporation of zinc species under controlled conditions, resulting in composites with varying ZnO contents. The physical and chemical properties of the materials were thoroughly characterized by SEM, Raman spectroscopy, and X-ray photoelectron spectroscopy, confirming the successful integration of ZnO within the carbon matrix and the formation of Zn-O-C chemical bonds. Photocatalytic tests, evaluated through the degradation of rhodamine 6G under UV irradiation, demonstrated that ZnO doping significantly improved photocatalytic efficiency, with the a-C@ZnO

Indexed as

charge transfer enhancementhydrothermal synthesisphotocatalysisrhodamine 6G degradationZnO doping

Identifiers

PMID41090832
PMCPMC12526421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.